MedPath
NMPA Approval

Moxifloxacin Hydrochloride Injection

国药准字H20193431

August 23, 2024

Drug Information

盐酸莫西沙星注射液

注射剂

20ml:0.4g(按C₂₁H₂₄FN₃O₄计)

化学药品

August 23, 2024

Company Information

Applicant Company

重庆市北碚区水土镇方正大道21号

Manufacturing Company

重庆市北碚区水土镇方正大道21号附1号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸莫西沙星注射液 - NMPA 批准文号 | MedPath